Intrarosa

Urology FDA approvals of 2016Urology-related FDA approvals from 2016 encompassed drugs and devices for prostate cancer, renal cell carcinoma, bladder cancer, stone disease, and more.
New Products: Hybrid basket, grabber provides capture, release of multiple stone sizesOther products discussed include a stent system for treating ureteral obstructions, a male infertility test, and more.